v3.26.3
Equity
 9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Equity Equity
Common StockAdditional paid-in capitalRetained earningsAccumulated other
comprehensive income (loss)		Treasury stockTotal Equity
In millions, shares in thousandsSharesAmount
Balance at December 31, 202543,892 $0.4 $195.7 $404.9 $0.5 $(571.8)$29.7 
Net income (loss)— — — 59.8 — — 59.8 
Other comprehensive income (loss)— — — — (2.1)— (2.1)
Common stock issued171 — — — — — — 
Exercise of stock options, net59 — 3.3 — — — 3.3 
Tax payments related to vested restricted stock units— — — — — (4.3)(4.3)
Share repurchase program— — — — — (52.3)(52.3)
Share-based compensation plans— — 4.4 — — 0.4 4.8 
Balance at March 31, 202644,122 $0.4 $203.4 $464.7 $(1.6)$(628.0)$38.9 
Net income (loss)— $— $— $35.3 $— $— $35.3 
Other comprehensive income (loss)— — — — 2.6 — 2.6 
Common stock issued67 — — — — — — 
Exercise of stock options, net28 — 1.8 — — — 1.8 
Tax payments related to vested restricted stock units— — — — — (1.3)(1.3)
Share repurchase program— — — — — (35.1)(35.1)
Share-based compensation plans— — 3.9 — — 0.8 4.7 
Balance at June 30, 202644,217 $0.4 $209.1 $500.0 $1.0 $(663.6)$46.9 
Net income (loss)— — — 49.3 — — 49.3 
Other comprehensive income (loss)— — — — 1.8 — 1.8 
Common stock issued20 — — — — — — 
Exercise of stock options, net1 — — — — — — 
Tax payments related to vested restricted stock units— — — — — (0.5)(0.5)
Share repurchase program— — — — — (38.9)(38.9)
Share-based compensation plans— — 4.0 — — 0.4 4.4 
Balance at September 30, 202644,238 $0.4 $213.1 $549.3 $2.8 $(702.6)$63.0 
Common StockAdditional paid-in capitalRetained earningsAccumulated other
comprehensive income (loss)		Treasury stockTotal Equity
In millions, shares in thousandsSharesAmount
Balance at December 31, 202443,630 $0.4 $176.8 $572.0 $(41.4)$(512.6)$195.2 
Net income (loss)— — — 20.5 — — 20.5 
Other comprehensive income (loss)— — — — 17.4 — 17.4 
Common stock issued155 — — — — — — 
Tax payments related to vested restricted stock units— — — — — (2.6)(2.6)
Share-based compensation plans— — 4.1 — — — 4.1 
Balance at March 31, 202543,785 $0.4 $180.9 $592.5 $(24.0)$(515.2)$234.6 
Net income (loss)— $— $— $(146.5)$— $— $(146.5)
Other comprehensive income (loss)— — — — 28.2 — 28.2 
Common stock issued15 — — — — — — 
Share-based compensation plans— — 4.4 — — — 4.4 
Balance at June 30, 202543,800 $0.4 $185.3 $446.0 $4.2 $(515.2)$120.7 
Net income (loss)— — — 43.5 — — 43.5 
Other comprehensive income (loss)— — — — (6.6)— (6.6)
Common stock issued9 — — — — — — 
Exercise of stock options, net22 — 0.6 — — — 0.6 
Tax payments related to vested restricted stock units— — — — — (0.2)(0.2)
Share repurchase program— — — — — (25.2)(25.2)
Share-based compensation plans— — 5.3 — — — 5.3 
Balance at September 30, 202543,831 $0.4 $191.2 $489.5 $(2.4)$(540.6)$138.1 
Accumulated other comprehensive income (loss)
Three Months Ended September 30,Nine Months Ended September 30,
In millions2026202520262025
Foreign currency translation
Beginning balance$(1.8)$2.3 $(1.9)$(44.4)
Gains (losses) on foreign currency translation2.0 (5.8)2.1 40.9 
Other comprehensive income (loss), net of tax2.0 (5.8)2.1 40.9 
Ending balance$0.2 $(3.5)$0.2 $(3.5)
Derivative instruments
Beginning balance$(0.6)$(0.6)$(1.0)$0.5 
Gains (losses) on derivative instruments(0.5)(0.9)(0.1)(2.6)
Less: tax provision (benefit)(0.1)(0.2)— (0.6)
Net gains (losses) on derivative instruments(0.4)(0.7)(0.1)(2.0)
(Gains) losses reclassified to net income0.3 (0.2)0.4 0.1 
Less: tax (provision) benefit0.1 (0.1)0.1 — 
Net (gains) losses reclassified to net income0.2 (0.1)0.3 0.1 
Other comprehensive income (loss), net of tax(0.2)(0.8)0.2 (1.9)
Ending balance$(0.8)$(1.4)$(0.8)$(1.4)
Pension and other postretirement benefits
Beginning balance$3.4 $2.5 $3.4 $2.5 
Other comprehensive income (loss), net of tax— — — — 
Ending balance$3.4 $2.5 $3.4 $2.5 
Total AOCI ending balance at September 30$2.8 $(2.4)$2.8 $(2.4)
Reclassifications of accumulated other comprehensive income (loss)
Three Months Ended September 30,Nine Months Ended September 30,
In millions2026202520262025
Derivative instruments
Currency exchange contracts (1)
$— $(0.1)$— $(0.3)
Natural gas contracts (2)
(0.3)0.3 (0.4)0.2 
Total before tax(0.3)0.2 (0.4)(0.1)
(Provision) benefit for income taxes0.1 (0.1)0.1 — 
Amount included in net income (loss)$(0.2)$0.1 $(0.3)$(0.1)
_______________
(1) Included within "Net sales" on the condensed consolidated statements of operations.
(2) Included within "Cost of sales" on the condensed consolidated statements of operations.
Share Repurchases
On July 25, 2022, our Board of Directors authorized the repurchase of up to $500.0 million of our common stock (the "2022 Authorization"), and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares under the 2022 Authorization may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of prevailing market conditions and other factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
During the three months ended September 30, 2026, we repurchased $38.9 million, inclusive of $0.4 million in excise tax, in common stock, representing 538,979 shares of our common stock at an average cost per share of $71.45. During the nine months ended September 30, 2026, we repurchased $126.3 million, inclusive of $1.0 million in excise tax, in common stock, representing 1,804,168 shares of our common stock at an average cost per share of $69.44. At September 30, 2026, $172.2 million remained unused under the 2022 Authorization.
During the three and nine months ended September 30, 2025, we repurchased $25.2 million, inclusive of $0.2 million in excise tax, in common stock, representing 445,724 shares of our common stock at an average cost per share of $56.09. At September 30, 2025, $328.4 million remained unused under the 2022 Authorization.